Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1994402rdf:typepubmed:Citationlld:pubmed
pubmed-article:1994402lifeskim:mentionsumls-concept:C0042071lld:lifeskim
pubmed-article:1994402lifeskim:mentionsumls-concept:C0332835lld:lifeskim
pubmed-article:1994402lifeskim:mentionsumls-concept:C0221464lld:lifeskim
pubmed-article:1994402lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:1994402lifeskim:mentionsumls-concept:C1947917lld:lifeskim
pubmed-article:1994402lifeskim:mentionsumls-concept:C2348331lld:lifeskim
pubmed-article:1994402lifeskim:mentionsumls-concept:C0023981lld:lifeskim
pubmed-article:1994402lifeskim:mentionsumls-concept:C0206034lld:lifeskim
pubmed-article:1994402lifeskim:mentionsumls-concept:C0205265lld:lifeskim
pubmed-article:1994402lifeskim:mentionsumls-concept:C0302891lld:lifeskim
pubmed-article:1994402lifeskim:mentionsumls-concept:C1555582lld:lifeskim
pubmed-article:1994402pubmed:issue3lld:pubmed
pubmed-article:1994402pubmed:dateCreated1991-3-21lld:pubmed
pubmed-article:1994402pubmed:abstractTextThe effects of two urokinase (UK) dose regimens on lysis time, lytic success, primary clinical success, and frequency of complications of peripheral thrombolysis were compared. Seventy-two intraarterial UK infusions were performed by means of standard catheter-directed infusion techniques in 63 patients with symptomatic peripheral arterial or bypass graft occlusions. Patients were prospectively randomized to high-dose (250,000 U/h for 4 hours and then 125,000 U/h) or low-dose (50,000 U/h) regimens. The mean time to complete lysis was 20.8, 26.0, 16.5, and 18.2 hours for the high-dose artery, low-dose artery, high-dose graft, and low-dose graft groups, respectively (P was not significant). Respective mean infusion durations were 27.1, 35.4, 22.2, and 25.3 hours. Clinical success was achieved in 65%-85% of cases. The frequency of complications was equivalent between groups, except for a higher frequency of minor bleeding complications in the high-dose group. The two urokinase dose regimens studied were equally effective in enabling peripheral thrombolysis.lld:pubmed
pubmed-article:1994402pubmed:languageenglld:pubmed
pubmed-article:1994402pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1994402pubmed:citationSubsetAIMlld:pubmed
pubmed-article:1994402pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1994402pubmed:statusMEDLINElld:pubmed
pubmed-article:1994402pubmed:monthMarlld:pubmed
pubmed-article:1994402pubmed:issn0033-8419lld:pubmed
pubmed-article:1994402pubmed:authorpubmed-author:CorsonJ DJDlld:pubmed
pubmed-article:1994402pubmed:authorpubmed-author:SmithT PTPlld:pubmed
pubmed-article:1994402pubmed:authorpubmed-author:NakagawaNNlld:pubmed
pubmed-article:1994402pubmed:authorpubmed-author:BerbaumK SKSlld:pubmed
pubmed-article:1994402pubmed:authorpubmed-author:CraggA HAHlld:pubmed
pubmed-article:1994402pubmed:authorpubmed-author:KresowikT FTFlld:pubmed
pubmed-article:1994402pubmed:authorpubmed-author:SharpW JWJlld:pubmed
pubmed-article:1994402pubmed:authorpubmed-author:CastanedaFFlld:pubmed
pubmed-article:1994402pubmed:authorpubmed-author:ShammaAAlld:pubmed
pubmed-article:1994402pubmed:issnTypePrintlld:pubmed
pubmed-article:1994402pubmed:volume178lld:pubmed
pubmed-article:1994402pubmed:ownerNLMlld:pubmed
pubmed-article:1994402pubmed:authorsCompleteYlld:pubmed
pubmed-article:1994402pubmed:pagination681-6lld:pubmed
pubmed-article:1994402pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:1994402pubmed:meshHeadingpubmed-meshheading:1994402-...lld:pubmed
pubmed-article:1994402pubmed:meshHeadingpubmed-meshheading:1994402-...lld:pubmed
pubmed-article:1994402pubmed:meshHeadingpubmed-meshheading:1994402-...lld:pubmed
pubmed-article:1994402pubmed:meshHeadingpubmed-meshheading:1994402-...lld:pubmed
pubmed-article:1994402pubmed:meshHeadingpubmed-meshheading:1994402-...lld:pubmed
pubmed-article:1994402pubmed:meshHeadingpubmed-meshheading:1994402-...lld:pubmed
pubmed-article:1994402pubmed:meshHeadingpubmed-meshheading:1994402-...lld:pubmed
pubmed-article:1994402pubmed:meshHeadingpubmed-meshheading:1994402-...lld:pubmed
pubmed-article:1994402pubmed:meshHeadingpubmed-meshheading:1994402-...lld:pubmed
pubmed-article:1994402pubmed:meshHeadingpubmed-meshheading:1994402-...lld:pubmed
pubmed-article:1994402pubmed:meshHeadingpubmed-meshheading:1994402-...lld:pubmed
pubmed-article:1994402pubmed:meshHeadingpubmed-meshheading:1994402-...lld:pubmed
pubmed-article:1994402pubmed:meshHeadingpubmed-meshheading:1994402-...lld:pubmed
pubmed-article:1994402pubmed:year1991lld:pubmed
pubmed-article:1994402pubmed:articleTitleTwo urokinase dose regimens in native arterial and graft occlusions: initial results of a prospective, randomized clinical trial.lld:pubmed
pubmed-article:1994402pubmed:affiliationDepartment of Radiology, University of Iowa College of Medicine, Iowa City.lld:pubmed
pubmed-article:1994402pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1994402pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:1994402pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:1994402pubmed:publicationTypeRandomized Controlled Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1994402lld:pubmed